Cargando…
Lymphopenia in COVID-19: γδ T Cells-Based Therapeutic Opportunities
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection dysregulates the immune system by lymphopenia of B cells, monocytes, eosinophils, basophils, and cytotoxic cells such as CD8, γδ T cells, and natural killer (NK) cells. Despite many studies being conducted to better understand th...
Autores principales: | Lo Presti, Elena, Dieli, Francesco, Meraviglia, Serena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228064/ https://www.ncbi.nlm.nih.gov/pubmed/34071430 http://dx.doi.org/10.3390/vaccines9060562 |
Ejemplares similares
-
γδ T cells and their clinical application in colon cancer
por: Corsale, Anna Maria, et al.
Publicado: (2023) -
Current Advances in γδ T Cell-Based Tumor Immunotherapy
por: Lo Presti, Elena, et al.
Publicado: (2017) -
Tumor-Infiltrating γδ T Lymphocytes: Pathogenic Role, Clinical Significance, and Differential Programing in the Tumor Microenvironment
por: Lo Presti, Elena, et al.
Publicado: (2014) -
γδ T Cells and Tumor Microenvironment: From Immunosurveillance to Tumor Evasion
por: Lo Presti, Elena, et al.
Publicado: (2018) -
Phenotypical and Functional Alteration of γδ T Lymphocytes in COVID-19 Patients: Reversal by Statins
por: Di Simone, Marta, et al.
Publicado: (2022)